Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acta Pharmaceuticals has raised $24M in Seed funding led by the Alzheimer’s Disease Research Foundation to advance its clinical candidate GSM-779690T for Alzheimer's therapies.
Amount Raised
$24 Million
Round Type
Seed
BostonHealthcareInvestors
Description
Acta Pharmaceuticals, Inc., based in Boston, MA, has secured $24M in Seed funding. The funding will be used to advance its lead clinical candidate, GSM-779690T. Backers include notable investors such as Dolby Family Ventures and Gamma Bio Investors. The company focuses on therapies for early intervention in Alzheimer’s disease.
Fundz sees it the moment Acta Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Acta Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.